my country's new crown vaccine is safe and effective

At a press conference held by the State Council's joint prevention and control mechanism on July 23, Feng Zijian, Executive Vice President and Secretary -General of the Chinese Association of Prevention Medicine, pointed out that the current new crown vaccine in my country has been inoculated 3.4 billion doses. The safety of the vaccine is very good; Wang Fusheng, director of the Department of Infectious Diseases, the Fifth Medical Center of the PLA General Hospital and the academician of the Chinese Academy of Sciences, said that a large number of clinical research evidence at home and abroad shows that the effects of new crown vaccines in my country are very significant Essence

The report rate of adverse reactions is slightly lower than the annual vaccination vaccination

Regarding the safety of vaccine, Feng Zijian introduced that as of May 30 this year, a total of more than 3.38 billion doses of new crown vaccines in the country were reported, and a total of 23,8215 cases were reported after vaccination, and the overall reporting rate was 70.45/1 million. The reporting rate of adverse reactions is slightly lower than the regular vaccination of regular vaccination.

Feng Zijian pointed out that my country has begun to prevent adverse incidents after vaccination in 2005. In 2010, disease -control institutions and drug adverse reactions were shared in real time to share the national monitoring report data in real time. In 2011 and 2014, my country's twice passed the WHO's evaluation of my country's national vaccine supervision system, marking the performance of the national vaccine supervision and monitoring system, including the adverse event monitoring system after vaccination, reached or surpassed the World Health Organization from the World Health Organization. Evaluation Criteria.

"After the launch of the new crown vaccination in my country, the medical and control institutions, medical institutions and drug adverse events monitoring institutions at all levels have conducted comprehensive and close monitoring of adverse events in the new crown vaccination through this monitoring system, and conducted causal correlation investigations, analysis and judgment. Feng Zijian introduced that in the bad incidents of the report, the general response accounted for 81.29%, the incidence rate was 57.27/1 million; the abnormal response accounted for 5.47%, and the incidence rate was 385/1 million. /1000000.

For the possibility of leukemia and diabetes mentioned on the Internet, Wang Fusheng pointed out that monitoring and research shows that inoculating new crown vaccines will not cause the occurrence of leukemia and diabetes, nor will it affect human genetic development as some network information says, and Tumor metastasis and proliferation, causing antibody dependence enhancement (ADE) phenomenon, these are irresponsible words on the Internet.

It complies with the standards for preventing diseases, prevention and death of the WHO for the setting of new crown vaccines

For the social concern of the effectiveness of vaccines, Wang Fusheng quoted a set of data. Recently, the epidemic in Hong Kong and Shanghai was mainly caused by Omikon poison. Studies have found that infected people aged 18 to 59 who have been vaccinated and strengthened throughout the process, the risk of developing from light to ordinary types is 63%and 65%lower than those who have not vaccinated vaccines, respectively. The risks developed into severe illnesses were 91%and 94%lower. For those who are infected with a full vaccination and enhanced inoculation, the risk of developing from light to ordinary types is 73%and 82%lower than those who have not vaccinated vaccines. The risk of developing from ordinary and below general types to severe diseases is more risks. Infected people who did not vaccine were 89%and 95%lower. It can be seen that my country's vaccine complies with the standards of the World Health Organization for the new crown vaccine.

So, is it important to take a reinforcement needle? Wang Fusheng said that a large number of clinical research evidence at home and abroad shows that strengthening immunity can further improve the protection effect.

Wang Fusheng also pointed out: "We should scientifically look at the protection of the new crown vaccine. First of all, after the human body is vaccinated, the immune response between different individuals is different, and the immune protection capacity is not exactly the same; secondly, in the second, in, in, in the case Among the people who have vaccinated vaccines, even if a breakthrough infection occurs, the risk of severe illnesses will be greatly reduced; again, people who vaccinate the vaccine still need to strengthen personal protection such as wearing masks, so as to better cope with the epidemic. "

my country's vaccine has a complete regulatory process for quality control

Wang Junzhi, the deputy leader of the expert group of the research and development of the research and development of the research and development of the research and development of the Scientific Research Research Research Group, pointed out that as of now, a total of 36 new crown vaccines in my country have been approved to enter the clinical trial stage. The evaluation of effectiveness is mainly based on the comprehensive relevant relevant regulations and technical guidance principles established in my country. Generally speaking, it is to complete the two important steps of preclinical research and clinical trials.

He said that my country's vaccine evaluation standards have not decreased. The reason why it can achieve rapid and efficient is mainly due to the joint prevention and control mechanism and institutional advantages, and innovatively adopted a series of measures such as early intervention, review linkage, and series transformation in series.

After the new crown vaccine was approved, there was actually a complete set of regulatory processes to ensure the quality of the vaccine. According to Wang Junzhi, first of all, before the factory is leaving the factory, the enterprise must be inspected in accordance with the national approval standards. The inspection items include physical indicators, chemical indicators, identification indicators, validity indicators, and safety indicators. Secondly, the national legal inspection agencies need to be approved and issued on the vaccine, which are inspected in accordance with national approval standards.

After my country's new crown vaccine is listed, the output has increased sharply. How to ensure the quality of vaccine? Wang Junzhi pointed out that the national legal institutions have transferred capable personnel in various provinces and expanded their ability to apply for issuance. At the same time, the pharmaceutical supervision institution also dispatched a inspector in the factory to the vaccine manufacturer to check the entire process of vaccine production to ensure that the production process meets the requirements of national regulations. At the same time, after the factory and use of the finished vaccine, there is a series of measures to ensure the quality of vaccine, such as establishing an independent running new crown vaccine information traceability regulatory system. The threat to the elderly is still very large

According to the WHO report, last week, China is in the Western Pacific region of China, an increase of 37%, which is the fastest growing area in the world. Omikon BA.5 Asian branches have spread to more than 100 countries and regions around the world, leading to an increase in the number of infections, hospitalization, and severe illnesses, and China's foreign defense input pressure has continued to increase.

So, can vaccine still have a protective effect? Zeng Yixin, deputy director of the National Health and Health Commission, the research and development of the research and development of the research and development of the research and development of the State Council's joint defense and control mechanism, and Zeng Yixin, an academician of the Chinese Academy of Sciences, pointed out that the existing research of the mutant strain showed that the serum of the vaccinator was targeted at BA.4 and BA.5 of the vaccine. Neutralization ability has declined, but the cellular immunity generated by vaccination is relatively good for virus mutation. The results of the real world also show that vaccination still has a good protection of pneumonia, severe and death caused by BA.4 and BA.5.

Zeng Yixin said that according to reports of many countries, the severity of the BA.4 and BA.5 infected people have not changed much compared with the early mutation strains of Omikon, but the threat to the elderly is still very large, especially not inoculating vaccination If the elderly who pass the vaccine infected BA.4 and BA.5, the risk of severe illness and death is still high.

Zeng Yixin introduced that as of July 22, 31 provinces (cities, districts) and Xinjiang Production and Construction Corps have reported a total of 341.6727 million doses of new crown vaccines, and the total number of vaccinations reached 129.636 million, of which 79.7985 million were completed and strengthened to strengthen the immunization. Immune vaccination rate is 71.7%. At present, at least 1 dose of vaccination rates over 60 years of age in my country are 89.6%, the basic immunization rate is 84.7%, and the immunization vaccination rate is 67.3%.

"From these data, the coverage of vaccination coverage of the entire population in my country and over 60 years of age has increased the vaccine over 60 years older than ever, but there is still room for improvement." Zeng Yixin said that it is mainly vaccination for elderly people over 80 years old. The coverage rate needs to be improved, and the strengthening rate of the elderly's strengthening need to be improved.

(Our newspaper

- END -